Canada Life’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-37,244
Closed -$626K 2346
2022
Q4
$626K Buy
37,244
+14,012
+60% +$237K ﹤0.01% 1660
2022
Q3
$398K Buy
23,232
+15,051
+184% +$236K ﹤0.01% 1733
2022
Q2
$64K Hold
8,181
﹤0.01% 2009
2022
Q1
$96K Buy
8,181
+3,547
+77% +$39.7K ﹤0.01% 2009
2021
Q4
$81K Hold
4,634
﹤0.01% 2059
2021
Q3
$94K Hold
4,634
﹤0.01% 2064
2021
Q2
$153K Buy
4,634
+1,149
+33% +$43.4K ﹤0.01% 1994
2021
Q1
$135K Hold
3,485
﹤0.01% 2032
2020
Q4
$152K Buy
3,485
+1,785
+105% +$61K ﹤0.01% 2026
2020
Q3
$48K Hold
1,700
﹤0.01% 2191
2020
Q2
$61K Buy
+1,700
New +$47.9K ﹤0.01% 2175

Canada Life's ONEM Position: Q1 2023 in Review

Canada Life sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 37,244 shares — an estimated $626K sold.

Canada Life first reported a position in ONEM in Q2 2020 and held it in 11 quarters. The position peaked at $626K in Q4 2022. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Canada Life reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Canada Life sold 37,244 1Life Healthcare shares in Q1 2023, an estimated $626K.
  • Canada Life first reported a position in 1Life Healthcare in Q2 2020 and held it in 11 quarters.
  • Canada Life's 1Life Healthcare position peaked at $626K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Canada Life's 13F filing for Q1 2023, filed 12 May 2023.